Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

US Patent 8541467 · Granted Sep 24, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hemat2016
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hemat2016
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hemat2016
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hemat2016
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hemat2016
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hemat2016
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin 2012
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin 2012
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin 2012
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin 2012
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin 2012
Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin 2012